ALX Oncology Holdings Inc. (ALXO)
NASDAQ: ALXO · Real-Time Price · USD
1.155
+0.005 (0.43%)
Nov 6, 2026, 4:00 PM EST - Market closed
ALX Oncology Holdings Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
48
Market Cap
159.71M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Sutro Biopharma | 45.70M |
| Zentalis Pharmaceuticals | 26.87M |
| MediWound | 11.86M |
| Whitehawk Therapeutics | 7.15M |
| Entrada Therapeutics | 3.98M |
| Oramed Pharmaceuticals | 2.00M |
| Inovio Pharmaceuticals | 65.34K |
ALXO News
- 5 weeks ago - ALX Oncology announces publication of data from ASPEN-06 Phase 2 trial - TheFly
- 5 weeks ago - ALX Oncology Announces Nature Medicine Publication of ASPEN-06 Phase 2 Clinical Data Demonstrating Strong Responses and Durable Clinical Benefit with Evorpacept in HER2-Positive Gastric Cancer - GlobeNewsWire
- 7 weeks ago - ALX Oncology Holdings Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts
- 1 month ago - ALX Oncology Holdings Transcript: 12th Annual Cantor Fitzgerald Global Healthcare Conference - Transcripts
- 1 month ago - ALX Oncology Holdings Transcript: Wells Fargo 21st Annual Healthcare Conference - Transcripts
- 2 months ago - ALX Oncology to Present at Upcoming Investor Conferences in September - GlobeNewsWire
- 3 months ago - ALX Oncology Reports Second Quarter 2026 Financial Results and Provides Corporate Update - GlobeNewsWire
- 3 months ago - ALX Oncology Holdings Earnings release: Q2 2026 - Filings